WFNMB2022/JSNM2022/JSNMT2022

Presentation information

Print

[WFNMB]Poster

The13th Congress of the World Federation of Nuclear Medicine and Biology(WFNMB2022) » [WFNMB]Poster Program

Therapy1

PSMA, PRRT, MIBG

Sun. Sep 11, 2022 8:00 AM - 8:00 PM Web distribution only (配信のみ)

[WP-20-2] Frequent, significant responses are observed with 177Lu-PSMA treatment in metastatic castration resistant prostate cancer, which associate to improved survival

Jukka Kemppainen1,2、Aki Kangasmäki 1、Simona Malaspina2,3、Kalevi Kairemo1、Juha Kononen1、Timo Joensuu1 (1.Docrates Cancer Center、2.University of Turku、3.Turku University Hospital)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

Password